China Proton Therapy Market Size, Status and Forecast to 2025

“China Proton Therapy Market Size, Status and Forecast to 2025” examines the market dynamics, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation, and future outlook for proton therapy in China. The research includes historic data from 2015 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. The report provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.The report further sheds light on the number of treatment rooms,current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at China proton therapy centers from 2008 to 2016.
The report also includes assessment of China reimbursement scenario; proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the China proton therapy market.
The report concludes with the profiles of major players in the China proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, China proton therapy centers developed by the companies and recent development of the proton therapy market.
The major companies dominating this market for its products, services and continuous product developments are:
Advanced Oncotherapy, Siemens Healthneers, ProNova Solution, ProTom International, Hitachi, Ion Beam Applications (IBA), Varian Medical Systems, Mevion Medical Systems
Long–term Growth Projection:
China represents a significant opportunity in the Global proton therapy market
China proton therapy market will exhibit a steady CAGR of over 30% by 2025
The potential China proton therapy market is likely to reach more than USD 10 Billion by 2025
IBA accounted highest number of proton therapy centers in the forecast period
Advanced Oncotherapy is emerging with novel technology and significantly impacting the proton
therapy market size over the forecast period
The Latest Industry Data Included in this Report:
Proton Therapy Current Applications
Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
Proton Therapy Competitive Analysis by Company
China Proton Therapy Market Size & Analysis (2015 – 2025)
China Proton Therapy Market Opportunity Assessment (2012 – 2025)
China Number of Treatment Rooms and Forecast (2017 – 2025)
China Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
China Number of Patients Treated at Proton Therapy Centers (2008 – 2016)
China Proton Therapy Reimbursement Scenario
Proton Therapy Center Component Analysis
Proton Therapy Clinical Trail Insight by Phase, Institute & Country
Major Deals in Proton Therapy Market
Key Market Drivers and Inhibitors of the China Proton Therapy Market
Major Companies Analysis
Key Deliverables in the Study
Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
Trending factors influencing the market of the China proton therapy market
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides a seven-year forecast which helps to provide a long-term assessment of developments in the China proton therapy market
Identification and analysis of the macro and micro factors that affect the China proton therapy market
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities
A comprehensive list of key market players along with the analysis of their current product portfolios and recent development

Non-Invasive Prenatal Testing (NIPT) Market Research Report Analysis 2017 – 2021

The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021.

For More Information Visit:

Long–term Growth Projection:

More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021.

Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow at the CAGR of XX% during 2017-2021.

Global Insulin Delivery Pen Market Research Report Analysis 2018 – 2025

Insulin Delivery Pen Market is expected to exceed US$ 14 Billion across the ten major markets (10MM) by 2025.
The report “Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 – 2017) and Future Forecast (2018 – 2025)” offers the most up-to-date industry data on the actual market situation and future outlook for insulin pen across the ten major markets (10MM). The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025. A comprehensive analysis has been done on market share of insulin pen segment.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.